Gyramides prevent bacterial growth by inhibiting DNA gyrase and altering chromosome topology

ACS Chemical Biology

Volumn 9, Issue 6, 2014, Pages 1312-1319

  Rajendram, Manohary ^a   Hurley, Katherine A ^a   Foss, Marie H ^a   Thornton, Kelsey M ^a   Moore, Jared T ^b   Shaw, Jared T ^b   Weibel, Douglas B ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE INHIBITOR; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; ENOXACIN; NOVOBIOCIN; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; ANTIINFECTIVE AGENT; BACTERIAL DNA; GYRAMIDE A; GYRASE INHIBITOR; PYRROLIDINE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; CHROMOSOME SEGREGATION; CHROMOSOME STRUCTURE; CROSS RESISTANCE; DNA REPLICATION; DNA SUPERCOILING; DRUG STRUCTURE; ESCHERICHIA COLI; GROWTH INHIBITION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; ANTIBIOTIC RESISTANCE; BACTERIAL CHROMOSOME; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; FLOW CYTOMETRY; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MUTATION;

ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; ANTI-BACTERIAL AGENTS; CHROMOSOMES, BACTERIAL; DNA GYRASE; DNA REPLICATION; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FLOW CYTOMETRY; MOLECULAR STRUCTURE; MUTATION; PYRROLIDINES; TOPOISOMERASE II INHIBITORS;

EID: 84903140170     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb500154m     Document Type: Article

References (36)

1. Wang, J. C. (2002) Cellular roles of DNA topoisomerases: a molecular perspective Nat. Rev. Mol. Cell Biol. 3, 430-440 (Pubitemid 34685700)
2. Champoux, J. J. (2001) DNA topoisomerases: structure, function, and mechanism Annu. Rev. Biochem. 70, 369-413 (Pubitemid 32662215)
3. Schoeffler, A. J. and Berger, J. M. (2008) DNA topoisomerases: harnessing and constraining energy to govern chromosome topology Q. Rev. Biophys. 41, 41-101
4. Collin, F., Karkare, S., and Maxwell, A. (2011) Exploiting bacterial DNA gyrase as a drug target: current state and perspectives Appl. Microbiol. Biotechnol. 92, 479-497
5. Fabrega, A., Madurga, S., Giralt, E., and Vila, J. (2009) Mechanism of action of and resistance to quinolones Microb. Biotechnol. 2, 40-61
6. Drlica, K. and Zhao, X. (1997) DNA gyrase, topoisomerase IV, and the 4-quinolones Microbiol. Mol. Biol. Rev. 61, 377-392 (Pubitemid 28090230)
7. Ng, E. Y., Trucksis, M., and Hooper, D. C. (1996) Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus Antimicrob. Agents Chemother. 40, 1881-1888 (Pubitemid 26277810)
8. Anderle, C., Stieger, M., Burrell, M., Reinelt, S., Maxwell, A., Page, M., and Heide, L. (2008) Biological activities of novel gyrase inhibitors of the aminocoumarin class Antimicrob. Agents Chemother. 52, 1982-1990 (Pubitemid 351758533)
9. Sissi, C. and Palumbo, M. (2003) The quinolone family: from antibacterial to anticancer agents Curr. Med. Chem. Anticancer Agents 3, 439-450 (Pubitemid 37236414)
10. Vila, J., Ruiz, J., Sanchez, F., Navarro, F., Mirelis, B., de Anta, M. T., and Prats, G. (1999) Increase in quinolone resistance in a Haemophilus influenzae strain isolated from a patient with recurrent respiratory infections treated with ofloxacin Antimicrob. Agents Chemother. 43, 161-162 (Pubitemid 29069217)
11. Karchmer, A. W. (2004) Increased antibiotic resistance in respiratory tract pathogens: PROTEKT US - an update Clin Infect Dis. 39 (Suppl 3) S142-150
12. Gellert, M., Mizuuchi, K., O'Dea, M. H., Itoh, T., and Tomizawa, J. I. (1977) Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity Proc. Natl. Acad. Sci. U.S.A. 74, 4772-4776 (Pubitemid 8227005)
13. Sugino, A., Peebles, C. L., Kreuzer, K. N., and Cozzarelli, N. R. (1977) Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme Proc. Natl. Acad. Sci. U.S.A. 74, 4767-4771 (Pubitemid 8227004)
14. Khodursky, A. B., Peter, B. J., Schmid, M. B., DeRisi, J., Botstein, D., Brown, P. O., and Cozzarelli, N. R. (2000) Analysis of topoisomerase function in bacterial replication fork movement: use of DNA microarrays Proc. Natl. Acad. Sci. U.S.A. 97, 9419-9424 (Pubitemid 30650790)
15. Cheung, K. J., Badarinarayana, V., Selinger, D. W., Janse, D., and Church, G. M. (2003) A microarray-based antibiotic screen identifies a regulatory role for supercoiling in the osmotic stress response of Escherichia coli Genome Res. 13, 206-215 (Pubitemid 36575769)
16. Falconer, S. B., Czarny, T. L., and Brown, E. D. (2011) Antibiotics as probes of biological complexity Nat. Chem. Biol. 7, 415-423
17. Foss, M. H., Eun, Y.-J., and Weibel, D. B. (2011) Chemical-biological studies of subcellular organization in bacteria Biochemistry. 50, 7719-7734
18. Shapiro, A. B. and Andrews, B. (2012) Allosteric inhibition of the DNA-dependent ATPase activity of Escherichia coli DNA gyrase by a representative of a novel class of inhibitors Biochem. Pharmacol. 84, 900-904
19. Bax, B. D., Chan, P. F., Eggleston, D. S., Fosberry, A., Gentry, D. R., Gorrec, F., Giordano, I., Hann, M. M., Hennessy, A., Hibbs, M., Huang, J., Jones, E., Jones, J., Brown, K. K., Lewis, C. J., May, E. W., Saunders, M. R., Singh, O., Spitzfaden, C. E., Shen, C., Shillings, A., Theobald, A. J., Wohlkonig, A., Pearson, N. D., and Gwynn, M. N. (2010) Type IIA topoisomerase inhibition by a new class of antibacterial agents Nature 466, 935-940
20. Black, M. T., Stachyra, T., Platel, D., Girard, A. M., Claudon, M., Bruneau, J. M., and Miossec, C. (2008) Mechanism of action of the antibiotic NXL101, a novel nonfluoroquinolone inhibitor of bacterial type II topoisomerases Antimicrob. Agents Chemother. 52, 3339-3349
21. Sawa, R., Takahashi, Y., Hashizume, H., Sasaki, K., Ishizaki, Y., Umekita, M., Hatano, M., Abe, H., Watanabe, T., Kinoshita, N., Homma, Y., Hayashi, C., Inoue, K., Ohba, S., Masuda, T., Arakawa, M., Kobayashi, Y., Hamada, M., Igarashi, M., Adachi, H., Nishimura, Y., and Akamatsu, Y. (2012) Amycolamicin: a novel broad-spectrum antibiotic inhibiting bacterial topoisomerase Chemistry 18, 15772-15781
22. Tohyama, S., Takahashi, Y., and Akamatsu, Y. (2010) Biosynthesis of amycolamicin: the biosynthetic origin of a branched alpha-aminoethyl moiety in the unusual sugar amycolose J. Antibiot. (Tokyo) 63, 147-149
23. Phillips, J. W., Goetz, M. A., Smith, S. K., Zink, D. L., Polishook, J., Onishi, R., Salowe, S., Wiltsie, J., Allocco, J., Sigmund, J., Dorso, K., Lee, S., Skwish, S., de la Cruz, M., Martin, J., Vicente, F., Genilloud, O., Lu, J., Painter, R. E., Young, K., Overbye, K., Donald, R. G., and Singh, S. B. (2011) Discovery of kibdelomycin, a potent new class of bacterial type II topoisomerase inhibitor by chemical-genetic profiling in Staphylococcus aureus Chem. Biol. 18, 955-965
24. Foss, M. H., Hurley, K. A., Sorto, N., Lackner, L. L., Thornton, K. M., Shaw, J. T., and Weibel, D. B. (2011) N-Benzyl-3-sulfonamidopyrrolidines are a new class of bacterial DNA gyrase inhibitors ACS Med. Chem. Lett. 2, 289-292
25. Mayer, C. and Janin, Y. L. (2013) Non-quinolone inhibitors of bacterial type IIA topoisomerases: A feat of bioisosterism Chem. Rev. 114, 2313-2342
26. Dorman, C. J., Lynch, A. S., Bhriain, N. N., and Higgins, C. F. (1989) DNA supercoiling in Escherichia coli: topA mutations can be suppressed by DNA amplifications involving the tolC locus Mol. Microbiol. 3, 531-540 (Pubitemid 19237673)
27. Tamayo, M., Santiso, R., Gosalvez, J., Bou, G., and Fernandez, J. L. (2009) Rapid assessment of the effect of ciprofloxacin on chromosomal DNA from Escherichia coli using an in situ DNA fragmentation assay BMC Microbiol. 9, 69
28. Mukherjee, A., Cao, C., and Lutkenhaus, J. (1998) Inhibition of FtsZ polymerization by SulA, an inhibitor of septation in Escherichia coli Proc. Natl. Acad. Sci. U.S.A. 95, 2885-2890 (Pubitemid 28135824)
29. Hill, T. M., Sharma, B., Valjavec-Gratian, M., and Smith, J. (1997) sfi-independent filamentation in Escherichia coli Is lexA dependent and requires DNA damage for induction J. Bacteriol. 179, 1931-1939 (Pubitemid 27123075)
30. Ferullo, D. J., Cooper, D. L., Moore, H. R., and Lovett, S. T. (2009) Cell cycle synchronization of Escherichia coli using the stringent response, with fluorescence labeling assays for DNA content and replication Methods 48, 8-13
31. Nollmann, M., Crisona, N. J., and Arimondo, P. B. (2007) Thirty years of Escherichia coli DNA gyrase: from in vivo function to single-molecule mechanism Biochimie 89, 490-499 (Pubitemid 46634704)
32. Basu, A., Schoeffler, A. J., Berger, J. M., and Bryant, Z. (2012) ATP binding controls distinct structural transitions of Escherichia coli DNA gyrase in complex with DNA Nat. Struct. Mol. Biol. 19 (538-546) S531
33. Nollmann, M., Stone, M. D., Bryant, Z., Gore, J., Crisona, N. J., Hong, S. C., Mitelheiser, S., Maxwell, A., Bustamante, C., and Cozzarelli, N. R. (2007) Multiple modes of Escherichia coli DNA gyrase activity revealed by force and torque Nat. Struct. Mol. Biol. 14, 264-271 (Pubitemid 46608338)
34. Sliusarenko, O., Heinritz, J., Emonet, T., and Jacobs-Wagner, C. (2011) High-throughput, subpixel precision analysis of bacterial morphogenesis and intracellular spatio-temporal dynamics Mol. Microbiol. 80, 612-627
35. Pankey, G. A. and Sabath, L. D. (2004) Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections Clin. Infect. Dis. 38, 864-870 (Pubitemid 38387236)
36. CLSI (2000) Methods for Dilution Antimicrobial Susceptiblility Tests for Bacteria That Grow Aerobically; Approved Standard-Fifth Edition, Clinical and Laboratory Standards Institute, Wayne, PA, Vol. 20.